Metagenomics Sequencing Market to be dominated by Whole genome sequencing & de novo assembly through 2028.
The rise in research and
development activities for development of new drugs is expected to drive the
growth of Global Metagenomics Sequencing Market during the forecast period,
2024-2028.
According to TechSci Research report, “Metagenomics Sequencing Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global Metagenomics Sequencing Market is anticipated to grow at an
impressive rate in the forecast period, 2024-2028. This can be ascribed
to the research and development activities for development of novel drugs and
growing demand for advanced sequencing technology across the region. Additionally,
growing applications of metagenomics in different fields such as
bioremediation, ecological and environmental metagenomics, clinical
diagnostics, drug development, and industrial use are the major factors driving
the growth of the market during the forecast period. Also, growing adoption of
bioinformatics technology in the diagnostic procedures and growing demand for
discovery of new proteins such as antibiotics by purifying, cloning, and
expressing DNA taken from the organisms will further boost the growth of the Global
Metagenomics Sequencing Market in the forecast period. Besides, Governments
around the world are providing support for development of healthcare industry,
including funding for research and development, which is driving the demand for
Metagenomics Sequencing Market during the forecast period.
However, the
cost of metagenomics sequencing can be high, particularly for high-throughput
sequencing technologies. This can slow down the growth of the Global Metagenomics
Sequencing Market in the forecast period. Also, Metagenomics sequencing
generates vast amounts of data that can be difficult to analyze and interpret.
Advanced bioinformatics tools and expertise are often required to extract
meaningful insights from the data, creating a challenge, further restricting the growth of the Global Metagenomics
Sequencing Market. Similarly, lack of standardization about metagenomics
sequencing machine along with Environmental samples can contain diverse
microbial communities with varying abundance levels, making it challenging to
capture and sequence the entire microbial diversity accurately that may hamper
the growth of the market during the forecast period.
Browse over XX market data
Figures spread through xx
Pages and an in-depth TOC on "Global Metagenomics Sequencing Market.”
Metagenomics Sequencing market
can be segmented by product and service, technology, application, and region.
Based on the Technology, the Global Metagenomics
Sequencing Market can be segmented into shotgun metagenomic
sequencing, 16S rRNA sequencing, whole genome sequencing & de novo
assembly, and meta transcriptomics. The whole genome sequencing & de novo assembly segment dominated
the market in 2022 and is expected to continue maintaining its dominance
throughout the forecast period. This can be ascribed to increasing Technological
breakthroughs about genomic sequencing such as meta proteomics, meta
transcriptomics along with rising research and development spending on the
genome research for the development of novel drugs, techniques for the
treatment of chronic diseases and
increased knowledge of metagenomics among healthcare providers. Also, growing investments
are being made by firms that are developing the next generation of genomics and
bioinformatics, i.e., expected to create lucrative growth during the forecast
period.
Based on Application, the market can be segmented
into drug discovery, ecological & environmental metagenomics, clinical
diagnostics, biofuel, and industrial applications. The drug discovery segment is expected to
dominate during the forecast period on account of the increasing research and
development activities on the genomic sequencing in the pharmaceutical and
biotechnology industries for novel drug discovery for exploring the
antimicrobial activity along with collaboration between market players and
academic institutes.
Major companies operating in the Global Metagenomics
Sequencing Market are:
·
BGI Genomics Co Ltd.
·
Eurofins Scientific Se.
·
Illumina Inc.
·
Macrogen Inc.
·
Oxford Nanopore Technologies Ltd.
·
Pacific Biosciences of California Inc.
·
Perkinelmer Inc.
·
Qiagen N.V.
·
Swift Biosciences Inc.
·
Thermo Fisher
Scientific Inc.
In December 2021, Oriel Research announced the launched
of metagenomics pipeline. It is being used for supporting metagenomics analysis
to allow the full synergism between big data used for bioinformatics analytical
tools and novel biological platforms, for delivering metagenomics discoveries
to patients.
In June 2021, Illumina announced an agreement with the
Belgian Genetic Centers to evaluate whole genome sequencing for the diagnosis
of patients with intellectual disabilities and developmental disorders.
Pacific Biosciences (PacBio) launched the Sequel II
System in 2019. This long-read sequencing platform offers high-accuracy
sequencing and longer read lengths, making it valuable for metagenomics studies.
The system allows for better assembly of complex microbial genomes and improved
characterization of microbial community structures.
In February 2021, PacBio announced that Childrens Mercy
Kansas City increased its investment in highly accurate HiFi sequencing with
four new Sequel Ile Systems to add to its two existing Sequel Ile Systems.
Download Sample Report
Customers can also request
for 10% free customization on this report.
“North
America is expected to dominate in the Global Metagenomics Sequencing Market \due
to the growing well established healthcare infrastructure along with growing
demand for advance sequencing technique for easy detection of diseases across
the region. Similarly, growing interest of researchers in the field of meta
transcriptomics, metabolomics, and metaproteomic and investments in
bioinformatics to promote metagenomics and microbiome is expected to create
lucrative growth in the market during the forecast period. Also, growing
concern about viral diseases such as hepatitis-B, HIV/AIDS, influenza, diarrhea
along with growing research and development for identifying the genes of the
viral diseases are expected to drive the growth of the market during the
forecast period. Furthermore, growing availability of technologically advanced product
and robust sample processing and library preparation assay kits for exploring
the genome activity , and the demand for efficient library preparation products
will further be expected to create lucrative opportunities for market growth”
said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
global management consulting firm.
“Metagenomics
Sequencing Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”
Segmented By Product and
Service (Reagents & consumables, Instruments, Services), By Technology
(Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing
& de novo assembly, Meta transcriptomics), By Application (Drug discovery,
Ecological & environmental metagenomics, Clinical diagnostics, Biofuel,
Industrial applications), By Region and By Competition”, has evaluated the future growth potential of global Metagenomics
Sequencing market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision-makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the Global Metagenomics
Sequencing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com